The company have demonstrably advanced the progress of an innovative solution for cardiac amyloidosis, leveraging the compound. Preliminary clinical data suggests significant improvements for patients suffering by this https://bridgebio465786.blogsmine.com/42452857/bridgebio-advances-amyloidosis-management-using-the-drug